Registry following people with non-small cell lung cancer in Germany
Collects data on lung cancer patients' tests, treatments and outcomes across Germany.
Plain-language title generated from the registry record
Registry title: National Network Genomic Medicine Lung Cancer, Germany
Key facts
- Where
- Cologne, GermanySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for adults in Germany with non-small cell lung cancer (NSCLC), whose data are collected and linked.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Proven NSCLC that is locally advanced or has spread (UICC stage IIIb/IV; cannot be removed by surgery). From 07/2023, also stage Ib, II, III (UICC).
Main reasons for not taking part
- No written informed consent
Read by machine on 12 November 2026.
Where in Germany
- University Hospital CologneCologne, GermanyContact: Anna RasokatTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Prof. Dr. Juergen Wolf
- Trial code
- NCT05934032
- Record updated
- 6 July 2023
- Original description
Registry of the national Network Genomic Medicine Lung Cancer (nNGM), linking data on molecular diagnostics, clinical characteristics, treatment patterns and outcomes of subjects with non-small cell lung cancer (NSCLC) from 23 specialized cancer centres and more than 400 general hospitals and oncological practices in GermanyRead full original descriptionShow less
Registry of the National Network Genomic Medicine Lung Cancer (nNGM), Linking Data on Molecular Diagnostics, Clinical Characteristics, Treatment Patterns and Outcomes of Subjects With Non-Small Cell Lung Cancer in Germany
Registry of the national Network Genomic Medicine Lung Cancer (nNGM), linking data on molecular diagnostics, clinical characteristics, treatment patterns and outcomes of subjects with non-small cell lung cancer (NSCLC) from 23 specialized cancer centres and more than 400 general hospitals and oncological practices in Germany
Inclusion: Age ≥ 18 years; Histologically confirmed, locally advanced or metastatic NSCLC (Union for International Cancer Control [UICC] stage IIIb/IV; non-resectable NSCLC); From 07/2023: histologically confirmed NSCLC stage Ib, II, III (UICC).
Exclusion: Missing written informed consent.